Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Payday loans today - instant payday loan apply now.
Popular Articles

Conference Invite: Unique Conference Specifically For Family Members Of OCD Sufferers, UK
OCD-UK is delighted to announce the first event of its kind, an OCD conference with a difference, a conference specifically aimed at the family, friends and carers of people with Obsessive-Compulsive Disorder (OCD).

Texas Medical Association Agrees: Texas Children Need Access To Health Care
Statement from Texas Medical Association President William H. Fleming III, MD, in response to today"s press conference by Sen. Eliot Shapleigh (D-El Paso) and Rep. Garnet Coleman (D-Houston). Senator Shapleigh and Representative Coleman called on Governor Rick Perry to add legislation that would expand the Children"s Health Insurance Program in the special session.
News of the day
Obama Names NYC Health Commissioner Frieden Next CDC Director
President Obama on Friday named New York City Health Commissioner Thomas Frieden as the new director of the Centers for Disease Control and Prevention, the New York Times reports. It has long been expected that Obama would select Frieden, an infectious disease specialist who is "widely admired" in the public health arena, according to the Times. In his seven years as health commissioner of New York City, Frieden pushed to establish HIV testing as a part of routine medical exams and defended a condom-distribution program that hands out more than 35 million condoms annually. Frieden is expected to take office in June and does not require Senate confirmation for the position. He will replace Richard Besser, the current acting director of CDC, who will return to his position as head of CDC"s coordinating office for terrorism preparedness and emergency response.The Times reports that Frieden will "inherit a host of immediate and long-term problems" at CDC, including organizational issues, low morale and the Obama administration"s health care reform agenda. "Health care reform also needs to be on his plate," Jeffrey Koplan, who served as CDC director from 1998 to 2002, said, adding, "There is a huge opportunity there to improve public health, and it"s one in which any CDC director will want to be a player." Several health care advocates praised the appointment, according to the Times. Dennis deLeon, president of the Latino Commission on AIDS in New York City said that Frieden is "willing to challenge the status quo in an effort to make a difference." Jeffrey Levi, executive director of the not-for-profit Trust for America"s Health, said Frieden is a "transformational leader" who "can take public health to a new place" (Harris/Hartocollis, New York Times, 5/15).
Cardiovascular

Painting Clearer Picture Of Biological Processes Using 'Microfluidic Palette'

The masterpieces that spring from the talents of Rembrandt, Van Gogh and other artists often begin with the creation of a gradient of colors on a palette. In a similar manner, researchers at the National Institute of Standards and Technology (NIST) have created an innovative device called the "microfluidic palette" to produce multiple, steady-state chemical gradients - gradual changes in concentration across an area - in a miniature chamber about the diameter of a pinhead. The tool can be used to study the complex biological mechanisms in cells responsible for cancer metastasis, wound healing, biofilm formation and other fluid-related processes. The advantage of the NIST system, as described in a new paper,* is that the gradients are generated by diffusion - the gentle movement of matter from one point to another by random molecular motion. Microfluidic systems usually mix fluids more actively, by pumps and the circulation of currents. Diffusion gradients allow cells being studied to remain in the microchamber without the chance of their being swept away. Diffusion also permits chemical molecules to move in and out of the cells naturally and eliminates the risk of shear stresses, commonly produced by currents, which could cause the cells to rupture or behave abnormally. The NIST microfluidic palette manages this with a clever plumbing trick. The key element of the palette is the microchamber, a small disk-shaped area only 1.5 millimeters (0.06 inch) across etched into the center of a glass wafer. Tiny holes at its circumference - three in the prototype, but it could be more - allow various mixtures to flow into the chamber. Beneath the chamber, each access port connects to the long tail of a Y-shaped channel etched into a second layer. These channels deliver test chemicals to the chamber. Fluid flow in and out of the short arms of each Y at constant pressure assures a constant stream of fresh chemicals. Because the pressure in the chamber is balanced by filling it previously with a buffer solution, the test chemicals that migrate from the channels into the chamber do so almost entirely by diffusion. Therefore, as long as a constant flow of fluid is maintained through the Y"s, the gradients in the chamber can be maintained virtually indefinitely. To demonstrate how the microfluidic palette works, the NIST researchers inject dyes of the three primary colors - red, yellow and blue - separately into the three inlets of the system. For each dye, an independent gradient forms that remains constant as long as flow rate into the system does not change. Overlapping the three gradients results in a blend of dye concentrations in which the combination of colors at one location is distinctly different from any other location. Similarly, if three separate drugs were injected into the palette where the microchamber contained a culture of cells, individual cells at different locations in the chamber would be exposed to different combinations of the drugs. In a single experiment, one could easily study the effects of a wide range of mixed drug concentrations on the same cell type. Another potential application of the microfluidic palette is the study of chemotaxis, the movement of cells along a chemical gradient, a biological phenomenon that plays a role in the spread of cancer (metastasis), wound healing, infection and carbon cycling in the ocean. The microfluidic palette technology is available for licensing. For more information, see the Federal Register, Vol. 74, No. 73, page 17819 (April 17, 2009). * J. Atencia, J. Morrow and L.E. Locascio. The microfluidic palette: A diffusive gradient generator with spatio-temporal control. Lab on a Chip. Posted online June 22, 2009. Michael E. Newman National Institute of Standards and Technology (NIST)


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009